The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hereditary Cancer Testing-Global Market Insights and Sales Trends 2024

Hereditary Cancer Testing-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1863524

No of Pages : 114

Ask Your Query

Synopsis
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.

The global Hereditary Cancer Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hereditary Cancer Testing in various end use industries. The expanding demands from the Breast Cancer, Gastrointestinal Cancer, Prostate Cancer and Respiratory/Lung Cancer, are propelling Hereditary Cancer Testing market. RNA Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DNA Testing segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Hereditary Cancer Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Hereditary Cancer Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hereditary Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hereditary Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hereditary Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hereditary Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hereditary Cancer Testing covered in this report include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity，Inc, ARUP Laboratories and Myriad, etc.
The global Hereditary Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
 

Market Segmentation
Company Profiles:

  • Ambry Genetics (Konica Minota)
  • Asper Biogene
  • Natera
  • Caris Life Sciences
  • BioReference Laboratories (GeneDx)
  • LabSolutions
  • Progenity，Inc
  • ARUP Laboratories
  • Myriad
  • NeoGenomics
  • Blueprint Genetics
  • CellMax Life
  • Fulgent Genetics
  • Strand Life Sciences
  • Myogenes
  • LabCorp
  • Quest Diagnostics
  • Pathway Genomics

Global Hereditary Cancer Testing market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Hereditary Cancer Testing market, Segment by Type:

  • RNA Testing
  • DNA Testing

Global Hereditary Cancer Testing market, by Application

  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Other Cancers

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hereditary Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Hereditary Cancer Testing
1.1 Hereditary Cancer Testing Market Overview
1.1.1 Hereditary Cancer Testing Product Scope
1.1.2 Hereditary Cancer Testing Market Status and Outlook
1.2 Global Hereditary Cancer Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hereditary Cancer Testing Market Size by Region (2018-2029)
1.4 Global Hereditary Cancer Testing Historic Market Size by Region (2018-2023)
1.5 Global Hereditary Cancer Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hereditary Cancer Testing Market Size (2018-2029)
1.6.1 North America Hereditary Cancer Testing Market Size (2018-2029)
1.6.2 Europe Hereditary Cancer Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Hereditary Cancer Testing Market Size (2018-2029)
1.6.4 Latin America Hereditary Cancer Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Hereditary Cancer Testing Market Size (2018-2029)
2 Hereditary Cancer Testing Market by Type
2.1 Introduction
2.1.1 RNA Testing
2.1.2 DNA Testing
2.2 Global Hereditary Cancer Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hereditary Cancer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hereditary Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hereditary Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hereditary Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hereditary Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hereditary Cancer Testing Revenue Breakdown by Type (2018-2029)
3 Hereditary Cancer Testing Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer
3.1.2 Gastrointestinal Cancer
3.1.3 Prostate Cancer
3.1.4 Respiratory/Lung Cancer
3.1.5 Other Cancers
3.2 Global Hereditary Cancer Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hereditary Cancer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hereditary Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hereditary Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hereditary Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hereditary Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hereditary Cancer Testing Revenue Breakdown by Application (2018-2029)
4 Hereditary Cancer Testing Competition Analysis by Players
4.1 Global Hereditary Cancer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2022)
4.3 Date of Key Players Enter into Hereditary Cancer Testing Market
4.4 Global Top Players Hereditary Cancer Testing Headquarters and Area Served
4.5 Key Players Hereditary Cancer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Hereditary Cancer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ambry Genetics (Konica Minota)
5.1.1 Ambry Genetics (Konica Minota) Profile
5.1.2 Ambry Genetics (Konica Minota) Main Business
5.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Products, Services and Solutions
5.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Ambry Genetics (Konica Minota) Recent Developments
5.2 Asper Biogene
5.2.1 Asper Biogene Profile
5.2.2 Asper Biogene Main Business
5.2.3 Asper Biogene Hereditary Cancer Testing Products, Services and Solutions
5.2.4 Asper Biogene Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Asper Biogene Recent Developments
5.3 Natera
5.3.1 Natera Profile
5.3.2 Natera Main Business
5.3.3 Natera Hereditary Cancer Testing Products, Services and Solutions
5.3.4 Natera Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Caris Life Sciences Recent Developments
5.4 Caris Life Sciences
5.4.1 Caris Life Sciences Profile
5.4.2 Caris Life Sciences Main Business
5.4.3 Caris Life Sciences Hereditary Cancer Testing Products, Services and Solutions
5.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Caris Life Sciences Recent Developments
5.5 BioReference Laboratories (GeneDx)
5.5.1 BioReference Laboratories (GeneDx) Profile
5.5.2 BioReference Laboratories (GeneDx) Main Business
5.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Products, Services and Solutions
5.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 BioReference Laboratories (GeneDx) Recent Developments
5.6 LabSolutions
5.6.1 LabSolutions Profile
5.6.2 LabSolutions Main Business
5.6.3 LabSolutions Hereditary Cancer Testing Products, Services and Solutions
5.6.4 LabSolutions Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 LabSolutions Recent Developments
5.7 Progenity，Inc
5.7.1 Progenity，Inc Profile
5.7.2 Progenity，Inc Main Business
5.7.3 Progenity，Inc Hereditary Cancer Testing Products, Services and Solutions
5.7.4 Progenity，Inc Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Progenity，Inc Recent Developments
5.8 ARUP Laboratories
5.8.1 ARUP Laboratories Profile
5.8.2 ARUP Laboratories Main Business
5.8.3 ARUP Laboratories Hereditary Cancer Testing Products, Services and Solutions
5.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 ARUP Laboratories Recent Developments
5.9 Myriad
5.9.1 Myriad Profile
5.9.2 Myriad Main Business
5.9.3 Myriad Hereditary Cancer Testing Products, Services and Solutions
5.9.4 Myriad Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Myriad Recent Developments
5.10 NeoGenomics
5.10.1 NeoGenomics Profile
5.10.2 NeoGenomics Main Business
5.10.3 NeoGenomics Hereditary Cancer Testing Products, Services and Solutions
5.10.4 NeoGenomics Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 NeoGenomics Recent Developments
5.11 Blueprint Genetics
5.11.1 Blueprint Genetics Profile
5.11.2 Blueprint Genetics Main Business
5.11.3 Blueprint Genetics Hereditary Cancer Testing Products, Services and Solutions
5.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Blueprint Genetics Recent Developments
5.12 CellMax Life
5.12.1 CellMax Life Profile
5.12.2 CellMax Life Main Business
5.12.3 CellMax Life Hereditary Cancer Testing Products, Services and Solutions
5.12.4 CellMax Life Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.12.5 CellMax Life Recent Developments
5.13 Fulgent Genetics
5.13.1 Fulgent Genetics Profile
5.13.2 Fulgent Genetics Main Business
5.13.3 Fulgent Genetics Hereditary Cancer Testing Products, Services and Solutions
5.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Fulgent Genetics Recent Developments
5.14 Strand Life Sciences
5.14.1 Strand Life Sciences Profile
5.14.2 Strand Life Sciences Main Business
5.14.3 Strand Life Sciences Hereditary Cancer Testing Products, Services and Solutions
5.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Strand Life Sciences Recent Developments
5.15 Myogenes
5.15.1 Myogenes Profile
5.15.2 Myogenes Main Business
5.15.3 Myogenes Hereditary Cancer Testing Products, Services and Solutions
5.15.4 Myogenes Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Myogenes Recent Developments
5.16 LabCorp
5.16.1 LabCorp Profile
5.16.2 LabCorp Main Business
5.16.3 LabCorp Hereditary Cancer Testing Products, Services and Solutions
5.16.4 LabCorp Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.16.5 LabCorp Recent Developments
5.17 Quest Diagnostics
5.17.1 Quest Diagnostics Profile
5.17.2 Quest Diagnostics Main Business
5.17.3 Quest Diagnostics Hereditary Cancer Testing Products, Services and Solutions
5.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Quest Diagnostics Recent Developments
5.18 Pathway Genomics
5.18.1 Pathway Genomics Profile
5.18.2 Pathway Genomics Main Business
5.18.3 Pathway Genomics Hereditary Cancer Testing Products, Services and Solutions
5.18.4 Pathway Genomics Hereditary Cancer Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Pathway Genomics Recent Developments
6 North America
6.1 North America Hereditary Cancer Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hereditary Cancer Testing Market Dynamics
11.1 Hereditary Cancer Testing Industry Trends
11.2 Hereditary Cancer Testing Market Drivers
11.3 Hereditary Cancer Testing Market Challenges
11.4 Hereditary Cancer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock